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Conclusion:
Our results show a lower expression of PD-L1 in tumors of active smokers. PD-L2, VEGFR2 and VEGFR3 and HGF have a lower expression in tumors overall. Methylation data confirms these findings. The therapeutic ratio with targeted treatment might be narrow as a result of this higher expression in distant lung tissue and in the case of immune checkpoint inhibitors, increase the chance of pneumonitis. Oakland University, Biology, Rochester, USA Purpose or Objective: Recent studies have shown that alterations in the pattern of radiation delivery, such as pulsed radiotherapy (PRT), can produce significant changes to the tumor microenvironment. Given the positive effects of PRT on maintaining tumor vasculature, we hypothesized that PRT treatment would allow tumor microenvironments to remain more oxygenated and result in better overall tumor killing compared with SRT. We further postulated that this effect would be associated with decreased tumor hypoxia, leading to lower vascular endothelial growth factor (VEGF) and stromal derived factor-1 alpha (SDF-1α) production and subsequently lower recruitment of bone marrow derived cells (BMDCs) in PRT-irradiated tumors.
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Material and Methods: Subcutaneous Lewis lung carcinoma (LLC) tumors were established in C57BL/6 mice. Tumors were allowed to grow to 100-200mm3 before irradiation with a 160 kVp Faxitron cabinet (HVL: 0.77 mm Cu) using a dose rate of 0.69 Gy/min. SRT or PRT was given to 20 Gy at 2 Gy/day using a 5 day-on, 2 day-off schedule to mimic clinical delivery. Tumors were harvested 2-3 days post treatment. Radiation-induced changes in the tumor microenvironment were examined using flow cytometry and antibody-specific histopathology. Normal tissue effects were determined using non-invasive 18F-FDG PET/CT and MR imaging after naïve animals were given whole-lung irradiation to 40 Gy using the same 2 Gy/day regimens.
Results: PRT was more effective than SRT at reducing tumor growth rate (0.24±0.02mm3/day and 0.67±0.06mm3/day respectively; p<0.0001). Histopathology analysis showed a significant reduction in the levels of Ki-67 (13±8%), hypoxia (8±1%), VEGF (3.5±1%) and SDF-1α (4.2±1.5%) as well as a concomitant decrease in CD45+ BMDC migration (7.8±2.2%) after PRT when compared to SRT. Higher vessel density was also observed in PRT irradiated tumors. No short-term differences were observed in normal lung tissue after PRT or SRT although all irradiated animals demonstrated higher levels of inflammation than controls.
Conclusion:
Using a rapidly proliferating LLC allograft model, we have found evidence for improved tumor killing with PRT relative to SRT due to vascular maintenance. PRT irradiated tumors exhibited slower growth rate and reduced hypoxia coincident with loss of supportive mechanisms utilized by tumors in low oxygen microenvironments, such as angiogenesis and recruitment of BMDCs. This study demonstrates the efficacy of PRT and highlights the importance of microenvironment responses during tumor radiotherapy. We conclude that PRT represents an improved treatment strategy that may result in better overall patient outcomes with little alteration in normal tissue toxicity.
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